ReviewFarmaceuticos comunitarios2026
Interpretation of the ambulatory glucose profile in diabetes: practical application in community pharmacy.
Review in Farmaceuticos comunitarios, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The ambulatory glucose profile summarizes continuous glucose monitoring data and complements glycated hemoglobin by providing metrics of exposure, variability, and time spent in different glucose ranges. Objective: To review the key elements of the ambulatory glucose profile and propose a practical interpretation sequence applicable to community pharmacy. Material and methods: A targeted narrative review of PubMed/MEDLINE-indexed literature and scientific society recommendations was performed and complemented with official Spanish guidance, with the search updated through August 2026. Priority was given to consensus statements, clinical guidelines, validation studies of glucose metrics, and literature on pharmacist-led continuous glucose monitoring services. Results: Interpretation should begin by assessing data sufficiency, then prioritize time below range, evaluate time in range and time above range, review the glucose management indicator and coefficient of variation, and identify reproducible time-of-day patterns. Four anonymized real-world clinical profiles are presented for educational purposes together with a proposed community-pharmacy workflow. Conclusions: A structured review of the ambulatory glucose profile may support patient education, detection of glycemic-control problems, and interprofessional coordination without replacing clinical assessment or medication changes by the appropriate prescriber.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.